StockData
ADC Therapeutics SA logo

ADC Therapeutics SA (ADCT) shareholders

ADCTNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/30
$1.35+0.10 (+8.00%)

Close on Nov 17, 2026Market cap $172.35MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
72.9%
93M of 128M shares
Institutional holders
114
27 new, 30 sold out
Net institutional buying
10M
In Q2 2026
Insider trades, 12 months
0 buys · 6 sales
Net sold $19.64M

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Redmile Group, LLC
Joint filing with Jeremy C. Green (14.00%), RedCo II Master Fund, L.P. (11.70%)
15,666,73114.00%13G (passive) amendmentJun 30, 2025
Bain Capital Life Sciences Opportunities IV, L.P.14,825,6259.99%13G (passive)Oct 22, 2026
Jeremy C. Green
Joint filing with Redmile Group, LLC (9.90%), RedCo II Offshore SPV LLC (6.10%)
12,717,4879.90%13G (passive) amendmentApr 20, 2026
Daniel Mack
Joint filing with Nantahala Capital Management, LLC (9.69%), Wilmot B. Harkey (9.69%)
12,326,1849.69%13G (passive)Jun 30, 2026
TCG Crossover GP II, LLC
Joint filing with TCG Crossover Fund II, L.P. (9.20%), Chen Yu (9.20%)
11,390,1759.20%13G (passive)Oct 27, 2025
Dr. Hans-Peter Wild
Joint filing with Hpwh Th AG (8.52%)
9,788,9449.61%13G (passive) amendmentMay 15, 2025
W. Lawrence Hawkins
Joint filing with Prosight Management, LP (6.80%), Prosight Partners, LLC (6.80%)
8,477,3386.80%13G (passive) amendmentDec 31, 2025
Prosight Management, LP
Joint filing with Prosight Partners, LLC (5.80%), W. Lawrence Hawkins (5.80%)
7,195,3745.80%13G (passive) amendmentSep 30, 2025
BlackRock, Inc.6,857,8155.40%13G (passive)Jun 30, 2026

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of ADCTValueChange% of portfolio
Nantahala Capital Management, LLC24,652,36819.31%$26.38M+19,054,9350.44%
Redmile Group, LLC11,526,7109.03%$12.33M−3,943,7920.83%
TCG Crossover Management, LLC11,390,1758.92%$12.19M–0.29%
Prosight Management, LP7,824,7496.13%$8.37M−475,2511.44%
BlackRock, Inc.7,020,0935.50%$7.51M+769,3460.00%
Point72 Asset Management, L.P.3,649,1442.86%$3.90M+267,0150.00%
Morgan Stanley3,051,1732.39%$3.26M−761,4090.00%
Millennium Management LLC2,899,5352.27%$3.10M−219,6190.00%
Citadel Advisors LLC2,053,3161.61%$2.20M+1,653,5950.00%
Goldman Sachs Group Inc1,914,4241.50%$2.05M+261,3980.00%
State Street Corp1,685,8361.32%$1.80M+119,1740.00%
Geode Capital Management, LLC1,445,5461.13%$1.55M+241,7900.00%
Bank Of America Corp /De/1,288,2061.01%$1.38M−36,8110.00%
Vanguard Portfolio Management LLC897,0920.70%$959.89K−136,1850.00%
Two Sigma Investments, LP773,4140.61%$827.55K+105,3920.00%
Blue Owl Capital Holdings LP733,5680.57%$784.92K–0.12%
D. E. Shaw & Co., Inc.719,3200.56%$769.67K+476,1440.00%
Opaleye Management Inc.700,0000.55%$749.00KNew0.07%
Aqr Capital Management LLC658,1250.52%$704.19K+420,4880.00%
Bnp Paribas Arbitrage, Snc652,8490.51%$698.55K−207,6420.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 202611493M72.9%27 / 4230 / 3026M16M
Q1 202611884M65.4%19 / 5229 / 1410M8M
Q4 202511583M64.9%21 / 4828 / 1223M8M
Q3 202510668M53.4%23 / 3023 / 39M8M
Q2 20258668M53.2%14 / 1739 / 1015M2M
Q1 20258255M43.0%13 / 2720 / 132M3M
Q4 20248356M44.3%16 / 3316 / 107M6M
Q3 20247755M43.1%19 / 3310 / 1410M3M
Q2 20247452M40.6%45 / 127 / 820M8M
Q1 20243740M31.4%11 / 79 / 1210M4M
Q4 20233835M27.2%8 / 710 / 114M9M
Q3 20234139M30.9%4 / 1413 / 182M7M

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Ameet MallikChief Executive Officer, Director2,790,8702.19%Jul 2, 2026
Mohamed ZakiChief Medical Officer896,3170.70%Jul 2, 2026
Peter J. GrahamChief Legal Officer841,6400.66%Jul 2, 2026
Jose CarmonaChief Financial Officer938,0760.73%Jul 2, 2026
Lisa Michelle KalleboChief Accounting Officer128,2240.10%Feb 18, 2026
Viviane MongesDirector186,4470.15%Jun 3, 2026
Victor SandorDirector140,6860.11%Jun 3, 2026
Robert AzelbyDirector112,8050.09%Jun 3, 2026
Timothy CoughlinDirector72,4000.06%Jun 3, 2026
Jean-Pierre BizzariDirector139,3020.11%Jun 3, 2026
Ron SquarerDirector123,4310.10%Jun 3, 2026
Peter HugDirector263,3440.21%Jun 3, 2026
Jeremy Green10% owner28,812,44322.57%Apr 2, 2026
RedCo II Master Fund, L.P.10% owner38,233,26529.95%Apr 2, 2026
Redmile Group, LLC10% owner27,864,25721.83%Apr 2, 2026
Thomas Pfisterer–625,7550.49%May 19, 2025
Hans Peter Wild10% owner9,788,9447.67%May 19, 2025

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Ameet Mallik
Chief Executive Officer, Director
Jun 30, 2026Award+675,000––2,121,769
Peter J. Graham
Chief Legal Officer
Jun 30, 2026Award+221,100––841,640
Mohamed Zaki
Chief Medical Officer
Jun 30, 2026Award+213,900––896,317
Jose Carmona
Chief Financial Officer
Jun 30, 2026Award+203,700––938,076
Timothy Coughlin
Director
Jun 3, 2026Tax withholding−12,600$3.08$38.81K72,400
Ron Squarer
Director
Jun 3, 2026Tax withholding−15,196$3.08$46.80K123,431
Peter Hug
Director
Jun 3, 2026Tax withholding−2,156$3.08$6.64K263,344
Viviane Monges
Director
Jun 3, 2026Tax withholding−2,596$3.08$8.00K186,447
Jean-Pierre Bizzari
Director
Jun 3, 2026Tax withholding−12,600$3.08$38.81K139,302
Robert Azelby
Director
Jun 3, 2026Tax withholding−12,600$3.08$38.81K112,805
Victor Sandor
Director
Jun 3, 2026Tax withholding−12,600$3.08$38.81K140,686
Timothy Coughlin
Director
Jun 1, 2026Award+45,000––85,000
Ron Squarer
Director
Jun 1, 2026Award+45,000––138,627
Peter Hug
Director
Jun 1, 2026Award+45,000––265,500
Viviane Monges
Director
Jun 1, 2026Award+45,000––189,043
Jean-Pierre Bizzari
Director
Jun 1, 2026Award+45,000––151,902
Robert Azelby
Director
Jun 1, 2026Award+45,000––125,405
Victor Sandor
Director
Jun 1, 2026Award+45,000––153,286
RedCo II Master Fund, L.P.
10% owner
Apr 2, 2026Sale−2,529,491$3.28$8.30M10,265,297
RedCo II Master Fund, L.P.
10% owner
Apr 2, 2026Sale−2,634,506$3.28$8.64M12,666,731
RedCo II Master Fund, L.P.
10% owner
Apr 1, 2026Sale−169,265$3.80$643.21K15,301,237
RedCo II Master Fund, L.P.
10% owner
Apr 1, 2026Sale−162,517$3.80$617.56K12,794,788
RedCo II Master Fund, L.P.
10% owner
Mar 31, 2026Sale−188,407$3.75$706.53K12,957,305
RedCo II Master Fund, L.P.
10% owner
Mar 31, 2026Sale−196,229$3.75$735.86K15,470,502
Lisa Michelle Kallebo
Chief Accounting Officer
Feb 13, 2026Tax withholding−5,433$3.99$21.68K128,224
Lisa Michelle Kallebo
Chief Accounting Officer
Feb 13, 2026Award+62,900$3.99$250.97K133,657
Jose Carmona
Chief Financial Officer
Feb 13, 2026Tax withholding−25,880$3.99$103.26K734,376
Jose Carmona
Chief Financial Officer
Feb 13, 2026Award+271,600$3.99$1.08M760,256
Peter J. Graham
Chief Legal Officer
Feb 13, 2026Tax withholding−33,294$3.99$132.84K620,540
Peter J. Graham
Chief Legal Officer
Feb 13, 2026Award+294,800$3.99$1.18M653,834
Mohamed Zaki
Chief Medical Officer
Feb 13, 2026Award+285,200$3.99$1.14M707,020
Mohamed Zaki
Chief Medical Officer
Feb 13, 2026Tax withholding−24,603$3.99$98.17K682,417
Ameet Mallik
Chief Executive Officer, Director
Feb 13, 2026Award+900,000$3.99$3.59M1,550,000
Ameet Mallik
Chief Executive Officer, Director
Feb 13, 2026Tax withholding−103,231$3.99$411.89K1,446,769
Ameet Mallik
Chief Executive Officer, Director
Dec 6, 2025Tax withholding−233,146$3.29$767.05K1,319,101
Lisa Michelle Kallebo
Chief Accounting Officer
Dec 6, 2025Tax withholding−7,140$3.29$23.49K70,757
Jose Carmona
Chief Financial Officer
Dec 6, 2025Tax withholding−53,236$3.29$175.15K488,656
Mohamed Zaki
Chief Medical Officer
Dec 6, 2025Tax withholding−41,068$3.29$135.11K421,820
Peter J. Graham
Chief Legal Officer
Dec 6, 2025Tax withholding−49,508$3.29$162.88K359,034
Ron Squarer
Director
Jun 13, 2025Tax withholding−15,184$3.58$54.36K93,627
Victor Sandor
Director
Jun 13, 2025Tax withholding−12,600$3.58$45.11K108,286
Jean-Pierre Bizzari
Director
Jun 13, 2025Tax withholding−12,600$3.58$45.11K106,902
Peter Hug
Director
Jun 13, 2025Tax withholding−2,144$3.58$7.68K220,500
Viviane Monges
Director
Jun 13, 2025Tax withholding−2,584$3.58$9.25K144,043
Robert Azelby
Director
Jun 13, 2025Tax withholding−12,600$3.58$45.11K80,405
Viviane Monges
Director
Jun 3, 2025Award+40,000––146,627
Victor Sandor
Director
Jun 3, 2025Award+40,000––120,886
Peter Hug
Director
Jun 3, 2025Award+40,000––222,644
Robert Azelby
Director
Jun 3, 2025Award+40,000––93,005
Jean-Pierre Bizzari
Director
Jun 3, 2025Award+40,000––119,502
Ron Squarer
Director
Jun 3, 2025Award+40,000––108,811
Timothy Coughlin
Director
Jun 3, 2025Award+40,000––40,000
Thomas Pfisterer
–
May 15, 2025Other−451,856––173,899
Hans Peter Wild
10% owner
May 15, 2025Other+9,788,944––9,788,944
Ameet Mallik
Chief Executive Officer, Director
May 6, 2025Tax withholding−26,758$1.29$34.52K1,552,247
Peter J. Graham
Chief Legal Officer
Feb 13, 2025Award+220,000$1.61$354.20K408,542
Jose Carmona
Chief Financial Officer
Feb 13, 2025Award+240,000$1.61$386.40K541,892
Lisa Michelle Kallebo
Chief Accounting Officer
Feb 13, 2025Award+41,900$1.61$67.46K77,897
Ameet Mallik
Chief Executive Officer, Director
Feb 13, 2025Award+650,000$1.61$1.05M1,579,005
Mohamed Zaki
Chief Medical Officer
Feb 13, 2025Award+230,000$1.61$370.30K462,888

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
8.80%
6M shares short
Days to cover
6.7
At 1M shares a day
Change since last report
+1.4%
From 6M shares
Short volume, 20 days
46.5%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of ADC Therapeutics's stock actually held short. Settlement fails (shares not delivered on time) peaked at 10,900 shares on Sep 18, 2026 over the last 90 days.

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
Victor Sandor
Director
Jun 18, 20246,995$20.22KJun 17, 2024Vesting of Restricted Share Unit Grant
Jean-Pierre Bizzari
Director
Jun 18, 20246,995$20.22KJun 17, 2024Vesting of Restricted Share Unit Grant
Ron Squarer
Director
Jun 18, 20246,995$20.22KJun 17, 2024Vesting of Restricted Share Unit Grant
Robert Azelby
Director
Jun 18, 20246,995$20.22KJun 17, 2024Vesting of Restricted Share Unit Grant
Ameet Mallik
Officer and Director
May 7, 202429,731$134.19KMay 7, 2024Vesting of Restricted Share Unit Grant

See a number that looks wrong?